Mobile

This clinical study evaluates and compares the efficacy and safety of Regorafenib versus placebo in patients with coloreactal cancer after curative resection of liver metastasis and completion of all ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-004369-42

This clinical study evaluates and compares the efficacy and safety of Regorafenib versus placebo in patients with coloreactal cancer after curative resection of liver metastasis and completion of all planned chemotherapy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate and compare the efficacy and safety of regorafenib versus placebo in subjects with colorectal cancer (CRC) after curative resection of liver metastasis and completion of all planned chemotherapy.

Critère d'inclusion

  • Metastatic colorectal cancer

Liens